News | Catheters | February 21, 2019

Navitian Coronary Microcatheter Receives CE Mark Approval

Microcatheter designed for improved navigation in chronic total occlusions

Navitian Coronary Microcatheter Receives CE Mark Approval

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The device was approved to facilitate, guide and support a guidewire while accessing the coronary system, the exchange of guidewires, and injection of radiopaque contrast media or saline solutions.

Navitian was specifically designed to achieve a desirable navigation in cases of chronic total occlusions (CTOs). It stands out for its crossability and penetration capacity due to the internal and external conical transition.

Other key features of Navitian include:

  • Complete braided pattern that provides flexibility, pushability and resistance to kinking;

  • Hydrophilic coating Hydrax Plus having high trackability for small and tortuous arteries;

  • Internal polytetrafluoroethylene (PTFE) layer facilitating the movement of the guidewire during exchange; and

  • Sizes of 135 and 150 cm with guidewire compatibility of 0.014”.

For more information: www.ivascular.global

Related Content

News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
Subscribe Now